Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer.
Nov 2011 - :1873-2518 [PMID:22122856]
[Sims RB]

Current Vaccination Strategies for Prostate Cancer.
Okt 2011 - :1873-7560 [PMID:22001436]
[Joniau S] [Abrahamsson PA] [Bellmunt J] [Figdor C] [Hamdy F] [Verhagen P] [Vogelzang NJ] [Wirth M] [Van Poppel H] [Osanto S]

[Prostate carcinoma : Vaccination as a new option for treatment.]
Okt 2011 - :1433-0563 [PMID:21989588]
[Bedke J] [Gouttefangeas C] [Stenzl A]

Immunotherapy for Prostate Cancer: Biology and Therapeutic Approaches.
Aug 2011 - :1527-7755 [PMID:21825260]
[Cha E] [Fong L]

Sipuleucel-T: autologous cellular immunotherapy for men with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.
Jun 2011 - J Cancer; 2:1837-9664 [PMID:21716715]
[Sims RB]

Recent advances in immunotherapy for the treatment of prostate cancer.
Jun 2011 - Expert Opin Biol Ther; 11(8):1744-7682 [PMID:21675925]
[Sonpavde G] [Agarwal N] [Choueiri TK] [Kantoff PW]

Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer.
Jun 2011 - :1078-0432 [PMID:21558406]
[Beer TM] [Bernstein GT] [Corman JM] [Glode LM] [Hall SJ] [Poll WL] [Schellhammer PF] [Jones LA] [Xu Y] [Kylstra JW] [Frohlich MW]

Prostate Cancer Immunotherapy.
Jun 2011 - :1078-0432 [PMID:21700764]
[May KF] [Gulley JL] [Drake CG] [Dranoff G] [Kantoff PW]

Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research.
Jun 2011 - Clin. Cancer Res.; 17(12):1078-0432 [PMID:21680544]
[Gulley JL] [Drake CG]

Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis.
Mai 2011 - PLoS ONE; 6(4):1932-6203 [PMID:21533099]
[Draube A] [Klein-González N] [Mattheus S] [Brillant C] [Hellmich M] [Engert A] [von Bergwelt-Baildon M]

KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia.
Jan 2011 - :1464-5157 [PMID:21204621]
[Sahin E] [Sahin M] [Sanlioğlu AD] [Gümüslü S]

Sipuleucel-T: in metastatic castration-resistant prostate cancer.
Dez 2010 - Drugs; 71(1):0012-6667 [PMID:21175243]
[Plosker GL]

[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer].
Nov 2010 - Zhonghua Nan Ke Xue; 16(8):1009-3591 [PMID:21090344]
[Zhuang ZX] [Shen LQ] [Shi Y] [Lu X] [Shi HZ]

Dendritic cell-based immunotherapy for prostate cancer.
Nov 2010 - Clin. Dev. Immunol.; 2010:1740-2530 [PMID:21076523]
[Jähnisch H] [Füssel S] [Kiessling A] [Wehner R] [Zastrow S] [Bachmann M] [Rieber EP] [Wirth MP] [Schmitz M]

RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer.
Nov 2010 - Neoplasia; 12(11):1476-5586 [PMID:21076616]
[Kato T] [Ueda Y] [Kinoh H] [Yoneyama Y] [Matsunaga A] [Komaru A] [Harada Y] [Suzuki H] [Komiya A] [Shibata S] [Hasegawa M] [Hayashi H] [Ichikawa T] [Yonemitsu Y]